Loading clinical trials...
Loading clinical trials...
Treatment of Histamine Intolerance Using Probiotic Intervention - a Randomized Controlled Trial in Adults With Clinical Signs of Histamine Intolerance
Conditions
Interventions
Probio Histamed®, a multi-species probiotic preparation containing Bifid. breve, Bifid. lactis, Bifid. infantis, Bifid. longum, Lact. gasseri, and Lact. rhamnosus (5 x 10⁹ CFU per day)
Placebo Control
Locations
1
Germany
Zentrum für klinische Ernährung Stuttgart
Stuttgart, Germany
Start Date
May 2, 2024
Primary Completion Date
July 25, 2025
Completion Date
July 25, 2025
Last Updated
February 9, 2026
Lead Sponsor
University of Hohenheim
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions